NCT00403715View on ClinicalTrials.gov

Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions
Dry Eye Disease
Interventions
DRUG

diquafosol tetrasodium (INS365) Ophthalmic Solution

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00403715 - Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease | Biotech Hunter | Biotech Hunter